This is great news, but families can't just hand over the nasal spray form to their school nurse. The Texas law allowing ...
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
20d
GlobalData on MSNKenox and Lactiga partner on sIgA therapies for immunodeficiencyThe company, established in 2018 and based in the US state of New Jersey, focuses on pharma aerosol product development ...
A recent study led by Mass General Brigham researchers found that a nasal spray developed to target inflammation in the brain could be used to treat chronic symptoms of traumatic brain injury.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results